Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma

Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma: a Multicenter Randomized Controlled Trial

The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are :

Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare [arm information] to see if [insert effects].

Participants will be randomised in 2 groups.

• control group: patients will receive only advices about physical activities benefit
• interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).

Inclusion Criteria:

• newly diagnosed or relapse multiple myeloma, > 60 yo, not eligible to transplant
• 1st to 4th line of treatment initiated during the last 3 months
• receiving a systemic treatment that involved visit to the hospital at least twice a month durig the first 3 months and at least once a month the next 3 months

Exclusion Criteria:

• severe cardiac amyloidosis
• absolute contraindication to physical activity
• inability to comply with the protocol requirements
• not french speaker
• patient under guardianship or curatorship
• pregnant or lactating women